Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 7:9:663259.
doi: 10.3389/fpubh.2021.663259. eCollection 2021.

COVID-19: Heterogeneous Excess Mortality and "Burden of Disease" in Germany and Italy and Their States and Regions, January-June 2020

Affiliations

COVID-19: Heterogeneous Excess Mortality and "Burden of Disease" in Germany and Italy and Their States and Regions, January-June 2020

Peter Morfeld et al. Front Public Health. .

Abstract

Total mortality and "burden of disease" in Germany and Italy and their states and regions were explored during the first COVID-19 wave by using publicly available data for 16 German states and 20 Italian regions from January 2016 to June 2020. Based on expectations from 2016 to 2019, simplified Standardized Mortality Ratios (SMRs) for deaths occurring in the first half of 2020 and the effect of changed excess mortality in terms of "burden of disease" were assessed. Moreover, whether two German states and 19 Italian cities appropriately represent the countries within the European monitoring of excess mortality for public health action (EuroMOMO) network was explored. Significantly elevated SMRs were observed (Germany: week 14-18, Italy: week 11-18) with SMR peaks in week 15 in Germany (1.15, 95%-CI: 1.09-1.21) and in week 13 in Italy (1.79, 95%-CI: 1.75-1.83). Overall, SMRs were 1.00 (95%-CI: 0.97-1.04) in Germany and 1.06 (95%-CI: 1.03-1.10) in Italy. Significant SMR heterogeneity was found within both countries. Age and sex were strong modifiers. Loss of life expectancy was 0.34 days (1.66 days in men) for Germany and 5.3 days (6.3 days in men) for Italy [with upper limits of 3 and 6 weeks among elderly populations (≥65 years) after maximum potential bias adjustments]. Restricted data used within EuroMOMO neither represents mortality in the countries as a whole nor in their states and regions adequately. Mortality analyses with high spatial and temporal resolution are needed to monitor the COVID-19 pandemic's course.

Keywords: Germany; Italy; SARS-CoV-2/COVID-19; SMR; epidemiology; mortality excess.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Standardized Mortality Ratios (SMR) with extended 95% confidence intervals (CI, lo, hi) by week and month in Germany (G) and Italy (I) from January (week 1) to June 2020 (week 26) assuming a lognormal distribution of country-specific baseline death counts between 2016 and 2019.
Figure 2
Figure 2
Standardized Mortality Ratios (SMR) with extended 95% confidence intervals (CI, lo, hi) by week and month in Germany (G) and Italy (I) from January (week 1) to June 2020 (week 26) assuming a lognormal distribution of country-specific baseline death counts between 2016 and 2019: (A) females, (B) males, (C) age at death <65 years, (D) age at death ≥65 years.
Figure 3
Figure 3
Standardized Mortality Ratios (SMR) with extended 95% confidence intervals (CI, lo, hi) by week and month in (A) Thuringia (T) and Bavaria (B) and (B) Sicily (S) and Lombardy (L) from January (week 1) to June 2020 (week 26) assuming a lognormal distribution of region-specific baseline death counts between 2016 and 2019.

Similar articles

Cited by

References

    1. WHO . Pneumonia of Unknown Cause – China. Disease outbreak news 2020. 5 January 2020. (2020). Available online at: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-ch... (accessed November 8, 2020).
    1. WHO Regional Office for Europe . Coronavirus Disease (COVID-19) Pandemic. (2020). Available online at: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus... (accessed October 5, 2020).
    1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. . A new coronavirus associated with human respiratory disease in China. Nature. (2020) 579:265–9. 10.1038/s41586-020-2008-3 - DOI - PMC - PubMed
    1. Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. . Long-term consequences of COVID-19: research needs. Lancet Infect. Dis. (2020) 20:1115–7. 10.1016/S1473-3099(20)30701-5 - DOI - PMC - PubMed
    1. Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein S, Eckel RH, et al. . New-onset diabetes in Covid-19. N. Engl. J. Med. (2020) 383:789–90. 10.1056/NEJMc2018688 - DOI - PMC - PubMed

Publication types